Your search history is turned on.
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
STATEMENT OF EXECUTIVE COMPENSATION DATED: APRIL 26, 2024 1 | P a g e STATEMENT OF EXECUTIVE COMPENSATION Objective: The objective of this disclosure is to communicate the compensation th...
Date: April 18, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update VANCOUVER, BC, April 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the "MCTO"), by its principal regulator, ...
Date: April 10, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY VANCOUVER, BC, and Madison, WI April 10th, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. (SpayVac) jointly ...
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update VANCOUVER, BC, April 4, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the "MCTO"), by its principal regulator, t...
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE VANCOUVER, B.C., April 3, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:...
Date: March 22, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT VANCOUVER, BC, March 22, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") consisting of up to 15,384,615 units ("Units") at a price of $0.065 per Unit for to...
Date: March 21, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update VANCOUVER, BC, March 21, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the "MCTO"), by its principal regulator, ...
Date: March 8, 2024 Jurisdictions: Alberta, British Columbia, Ontario
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update VANCOUVER, BC, March 7, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024, (the "MCTO") by its principal regulator, t...
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order VANCOUVER, BC, March 6, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced that the Ontario Securities Commission (the "OSC"), as the Company's principal regulator, on February 2...
Date: March 7, 2024 Jurisdictions: Alberta, British Columbia, Ontario
[Execution Version] 140990457_21 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (the Agreement) is entered into as of February 11, 2024, by and among HIMV LLC, a Delaware limited liability company, as seller (Seller), and BioVaxys Technology Corp., a British Columbia-registered company, as purchaser (Purchaser). RECITALS WHEREAS, IMV Inc., a corpor...